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Calorie restriction is reported to enhance survival and delay the onset of age-related decline in many
different species. Several proteins have been proposed to play a role in mediating the response to
calorie restriction, including the target of rapamycin kinase, sirtuins, and AMP kinase. An enhanced
mechanistic understanding of calorie restriction has popularized the concept of ‘‘calorie restriction
mimetics’’, drugs that mimic the beneﬁcial effects of caloire restriction without requiring a reduc-
tion in nutrient intake. In theory, such drugs should delay the onset and progression of multiple
age-related diseases, similar to calorie restriction in mammals. Despite the potential beneﬁts of such
calorie restriction mimetics, however, relatively little is known about the interaction between
genetic variation and individual response to calorie restriction. Limited evidence from model sys-
tems indicates that genotype plays a large role in determining both the magnitude and direction
of effect that calorie restriction has on longevity. Here we present an overview of these data from
the perspective of using yeast as a model to study aging and describe an approach we are taking
to further characterize the molecular mechanisms underlying genotype-dependent responses to
calorie restriction.
 2012 Federation of European Biochemical Societies. Published by Elsevier B.V.1. Introduction
Aging is a highly complex biological process associated with
myriad physiological changes. As an organism matures, many of
the initial changes, such as increased strength and improved motor
skills, are beneﬁcial for reproductive success. However, later in life,
aging related processes tend to be detrimental. In humans,
advanced age is associated with increased incidence of many path-
ological processes such as heart disease, cancer, and neurodegener-
ative diseases. Therefore enhancing our understanding of the
molecular basis of aging may provide insight into the mechanisms
of age-related pathologies, and interventions that delay aging may
also prevent or delay multiple age-related diseases.
A number of genetic and environmental interventions have
been shown to increase life span in laboratory model organisms;
the best characterized of these is known as calorie restriction
(CR, also referred to as dietary restriction or DR). First reported in
1935, CR is deﬁned as a reduction in caloric intake without malnu-
trition [1]. CR has since been shown to increase life span in multi-
ple organisms including yeast, ﬂies, nematodes, mice, rats, and
monkeys [2–6]. In addition to the life span extending effects off Pathology, University of
SA. Fax: +1 206 543 3644.
al Societies. Published by ElsevierCR, experimental cohorts displayed reductions in age-related dis-
ease [6]. In one study of non-human primates, for example, ani-
mals subjected to CR maintained a more youthful appearance
and showed reduced incidences of cancer, cardiovascular disease,
and diabetes compared to age-matched controls fed ad libitum
[7]. Given the promising results from numerous species, signiﬁcant
interest has developed in using CR in humans as a means of
increasing life span and health span [8].
A key question in the ﬁeld is whether CR will have similar
effects on aging and age-related diseases in humans as has been
observed in laboratory animals. Although the answer to this ques-
tion remains unknown, controlled clinical trials have begun to
assess the feasibility and metabolic effects of short-term CR in
patients [9]. Studies of individuals who have been self-practicing
CR have also been reported, with evidence for similar metabolic
and physiological changes as those observed in laboratory animals,
including decreased levels of circulating IGF-1 and testosterone,
decreased blood pressure, reduced risk of cardiovascular disease
and diabetes, and reduced inﬂammation [10,11].
Genetic and molecular studies in model organisms have led to a
large of body of literature on the potential mechanisms bywhich CR
slows aging, and several proteins have been implicated inmediating
the beneﬁcial health effects of CR in different organisms, including
the target of rapamycin (TOR) kinase, the sirtuin family of protein
deacetylases and ADP ribosyltransferases, AMP-activated proteinB.V. Open access under CC BY-NC-ND license.
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ers (see Refs. [12–16] for reviews of this topic). One outcome of ad-
vances in understanding the mechanistic underpinnings of CR has
been popularization of the idea that pharmacological intervention
in pathways mediating CR could lead to similar positive effects on
aging and age-related diseases [17,18]. Sirtuin activators, TOR
inhibitors, and AMPK activators have all been proposed as CR
mimetics – pharmacological agents that mimic the effects of CR
on longevity and health without requiring reduced nutrient intake
[19–23]. Since it is generally recognized that getting a majority of
people to complywith a CR lifestyle is not feasible, the development
of bona ﬁde CRmimetics could allow a majority of individuals to re-
ceive the health beneﬁts of CRwithout requiring them to drastically
reduce their calorie consumption.
A careful analysis of the literature suggests, however, that in cer-
tain situations CR can have a negligible or even detrimental effect
on survival [24]. The individual response to CR will, of course, be
determined by a combination of environmental and genetic factors.
Relative to most laboratory studies, humans represent a genetically
and environmentally heterogeneous population. Therefore, before
CRmimetics becomewidely used, it will be important to gain a bet-
ter understanding of the interaction between nutrient availability,
other environmental parameters, and genotype.
2. Evidence for genotype-dependent responses to CR in model
organisms
Experiments performed in model organisms have yielded sev-
eral observations which demonstrate the important role that geno-
type plays in the response to CR. Studies in invertebrate species
aimed at deﬁning the genetic pathways involved in the response
to CR, for example, have identiﬁed numerous mutations that blunt,
abrogate, or enhance life span extension under CR conditions. For
example, in the nematode Caenorhabditis elegans, mutation or RNAi
knockdown of two different transcription factors, the forkhead
transcription factor PHA-4 or the heat shock transcription factor
HSF-1, completely prevents life span extension from CR [25,26].
In contrast, RNAi knockdown of the mitochondrial prohibitin com-
plex causes CR to extend life span to a much greater extent than in
wild type nematodes [27]. These speciﬁc cases, among others,
demonstrate that single-gene mutations can have a profound im-
pact on the effect of identical CR regimens on lifespan.
The importance of genetic variation has also been demonstrated
in mice, through studies that examined the life spans of ILS/ISS re-
combinant inbred mouse strains. The ILS/ISS strains were originally
derived from crosses between eight inbred mouse strains [28,29].
Progeny from these crosses were then subjected to selective breed-
ing for alcohol sensitivity. The resulting strains, therefore, share a
common origin but are genetically distinct. For these reasons the
ILS/ISS panel has proven to be a useful tool for studying multigenic
traits and complex phenotypes. Liao et al. [30] examined the life
spans of 41 ILS/ISS strains fed ad libitum or subjected to a CR diet
representing 60% of ad libitum consumption. The ILS/ISS strains
showed remarkable variation in life span under both feeding con-
ditions, with differences ranging from an increase in life span
exceeding 400% to a decrease of more than 90% in males from
two different strains (Fig. 1). Unexpectedly, the majority of ILS/
ISS strains did not experience a statistically signiﬁcant increase
in life span on CR. Only 5% of male strains and 21% of female strains
had their life span signiﬁcantly extended by CR [30]. These ﬁndings
are consistent with other studies that have failed to observe life
span extension in wild-derived and some inbred mouse strains
subjected to CR [24,31,32].
The mechanisms underlying the differential responses to CR in
the ILS/ISS strains are currently not understood. Liao et al. [30]
observed no correlations between the response to CR and gender,female fertility, or life span under ad libitum feeding. Subsequent
studies in the ILS/ISS strains have since suggested a correlation be-
tween the response to CR and the ability of mice to increase or
maintain fat mass while on a CR regimen [33]. ILS/ISS strains that
responded positively to CR maintained their fat mass better under
CR conditions than strains that responded poorly. There is evidence
to suggest, however, that fat mass itself is not the primary determi-
nant of CR longevity, since ob/ob mice, which are unable to produce
leptin and are genetically predisposed to obesity, have life spans
similar to wild-type mice when subjected to CR [34]. Therefore
the response to CR in mice is most likely not mediated by the pres-
ence or absence of fat, but perhaps is controlled by underlying met-
abolic processes that inﬂuence fat metabolism and storage under
conditions of limited nutrient availability.
As is the case for nearly all of the studies of CR in mice, the ILS/
ISS strains were derived from inbred lab strains, and it remains un-
clear whether the allelic diversity in inbred populations can serve
as a suitable model for genetic diversity in natural populations or
in humans. Thus, it may be that the effect of genotype on the re-
sponse to CR in the ILS/ISS mice may overestimate or underesti-
mate the true impact of genetic variation on the response to CR
in individual people. Nonetheless, these studies clearly demon-
strate that genetic variation in mice can strongly inﬂuence the ef-
fect of CR on longevity in a polygenic and complex manner and
illustrate the need for additional studies to deﬁne the molecular
mechanisms accounting for these differential responses.
3. Modeling aging and calorie restriction in yeast
The budding yeast Saccharomyces cerevisiae provides a useful
model for studying aging at the cellular level, due to its relatively
short life span and ease of genetic and environmental manipula-
tion [35]. Two types of aging have been described in yeast: replica-
tive and chronological. Replicative aging refers to the aging of
mitotically active cells, with replicative life span deﬁned as the
number of daughter cells a mother cell can produce before irre-
versible mitotic arrest [36]. Replicative life span is most commonly
measured by following individual mother cells maintained on rich
growth medium (YEPD, 1% yeast extract, 2% bacto peptone, 2%
glucose) and manually removing and counting daughter cells by
micromanipulation [38]. Chronological aging refers to the aging
of cells in a quiescence-like state, with chronological life span de-
ﬁned as the length of time that a non-dividing yeast cells can main-
tain replicative potential [37]. Chronological aging is most often
measured by culturing cells in synthetic deﬁned medium with glu-
cose as the carbon source, maintaining the cells in expired culture
medium, and periodically determining viability for a subset of the
population based on ability to resumemitotic growth under appro-
priate conditions (e.g. rich culture medium) [37].
CR has been shown to extend both chronological and replicative
life span in yeast [35]. In both aging paradigms, CR is generally
accomplished by reducing the glucose concentration of the culture
medium from 2% to either 0.5% or 0.05%. For simpliﬁcation, we
have chosen to limit our discussion here to the yeast replicative
aging paradigm; however, similar considerations apply equally to
the yeast chronological aging paradigm.
Although the use of yeast as a model for human aging has been
questioned [38], studies in yeast have proven pivotal in the discov-
ery of more than two dozen conserved aging genes [39]. In fact,
two of the most widely studied longevity pathways, the target of
rapamycin (TOR) pathway and the sirtuin family of protein deacet-
ylases, were ﬁrst shown to play a role in aging from studies per-
formed in yeast [40,41]. The method of inducing CR in yeast
(reducing glucose 4 to 40-fold) is clearly different from the primary
method of inducing CR in mammals, which most often involves a
20–40% reduction in overall caloric intake; however, there is
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Fig. 1. Reported effects of 40% calorie restriction in recombinant inbred mouse lines. Re-analysis of the data from Liao et al. [30] illustrating the percent change in life span in
41 mouse lines each subjected to 40% calorie restriction, relative to genetically matched ad libitum fed animals. Dark bars represent males and light bars represent females.
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responses to CR are shared. In particular, life span extension in
response to CR in yeast is mediated, at least in part, through re-
duced TOR signaling [42], which also appears to be the case in both
nematodes and fruit ﬂies [15,43]. As in yeast, CR in mice results in
inhibition of the mammalian TOR (mTOR) [44], and inhibition of
mTOR is sufﬁcient to extend life span in mice [45]. Thus, although
many aspects of human aging are not shared with yeast and other
non-mammalian species, there is no question that yeast has al-
ready proven to be an invaluable tool for the discovery and study
of conserved aging pathways.
The importance of genotype in the effect of CR on replicative life
span in yeast is evidenced by two observations. First, as in other
model organisms, speciﬁc mutations have been identiﬁed that alter
the effect of CR on life span. For example, deletion of the sirtuin
histone deacetylase Sir2 completely prevents replicative life span
extension from CR, while deletion of Sir2 combined with deletion
of the replication fork block protein Fob1 enhances life span exten-
sion from CR [46–48] (Fig. 2). Second, even among different ‘‘wild
type’’ laboratory strains, the same CR regimen can have dramati-
cally different effects on replicative life span (Table 1).
In order to begin to clarify the molecular and cellular processes
that inﬂuence the effect of genotype on life span extension from
CR, we have initiated a large-scale analysis of the effect of CR at
0.05% glucose on life span across more than 150 single-gene dele-
tion mutants. Our approach is based in part on experience gained
from our nearly completed analysis for more than 4500 single-
gene deletion strains contained in the haploid yeast ORF deletion
collections [49]. We are measuring replicative life span for individ-
ual single gene deletion strains within the same experiment under
both control (YEPD, 2% glucose) and CR (YEPD, 0.05% glucose) and
quantifying the change in life span in response to this level of CR.
The design of this study is, in principle, similar to that of Liao et al.
[30] who examined the effect of 40% CR on life span in recombinant
inbred mouse lines. There are a few important differences, how-
ever, which are described next.3.1. Genetic variation
The study performed by Liao et al. [30] utilized 41 recombinant
inbred lines that were generated from eight different inbred mouse
strains. Each strain is expected to differ from every other strain at
multiple loci, with the genetic variation limited to alleles present
in the initial inbred strains. Our study utilizes non-essential single
gene deletion strains from the yeast haploid ORF deletion collec-
tion [50]. As a consequence, our design is restricted to null alleles;
however, since each gene is non-essential, it is likely that many of
the deletion mutations are only partially defective for essential cel-
lular processes. For example, deletions that completely prevent
glycolysis will be lethal, while deletions that only partially impair
glycolysis and yield a viable cell can be assayed. A major advantage
of this approach is that we know the identity, and usually the func-
tion, of the deleted gene. Thus, it will be possible to assess the re-
sponse to CR based on functional grouping and GO Terms and,
perhaps, identify speciﬁc molecular processes or pathways that
show a characteristic differential response. This, in turn, should al-
low for the formulation of speciﬁc hypotheses regarding underly-
ing molecular mechanisms.
3.2. Sample size
Liao et al. [30] measured life span for 10 animals per strain (5
male/5 female) fed ad libitum or subjected to CR across 41 strains.
Our initial design involves measuring replicative life span for a
minimum of 20 cells per genotype under control or CR conditions
across more than 150 unique single-gene deletion strains. Life span
is then determined for additional cells on a case-by-case basis. A
major advantage of the yeast system is the relatively short time
frame required to perform longevity assays. This, combined with
the initially larger sample size for each genotype and larger num-
ber of genotypes examined, should allow us to have conﬁdence in
the initial observations and to rapidly validate and test speciﬁc
hypotheses in follow-up studies.
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Fig. 2. Theoretical and reported effects of calorie restriction on replicative life span.
(A) Some possible replicative life span (RLS) effects across a range of calorie
restriction (CR). Compared to a model wild-type life span response, represented by
strain 1, experimental strains could show an enhanced response to CR with (strain
2) or without (not shown) an altered response maximum, no change in RLS at any
level of restriction (strain 3), or a negative response to CR (strain 4). Mitochondrial
respiration becomes favored over fermentation as the glucose concentration drops.
This metabolic shift is thought to occur near 0.5% glucose and is represented by the
dashed line. (B) Representative published CR response proﬁles for a typical wild
type laboratory strain (BY4742) [52], and isogenic sir2D fob1D [52] and lat1D [64]
mutants.
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For initial screening purposes, we have chosen to utilize 0.05%
glucose as our method of CR. This level was chosen because it
has provided the most reproducible replicative life span exten-
sion in our hands in prior studies [47,51,52], and is similar to
the approach taken by Liao et al. [30] in that only one level ofTable 1
Reported changes in mean replicative life span in three different laboratory yeast strain b
following references: [42,47,48,51,52,55,64–72]. Values shown are percent change in life
experiment. N refers to the number of experiments included in the analysis. The genotype o
ade2–101 ura3–52 his3–200 leu2–3,112 lys2), W303 (MATa ade2–1 leu2–3 can1–100 trp1–1
Strain background 05% Glucose
Median percent change Range
BY4742 15 10 to 48
PSY316 25 18 to 51
W303AR5 6 8 to 23restriction (40%) was examined for the recombinant inbred
mouse lines. In select cases, however, we will perform additional
experiments examining the full response proﬁle for CR in those
genotypes by measuring replicative life span at additional glu-
cose concentrations (e.g. 1%, 0.5%, 0.1%, 0.01% 0.005% glucose),
similar to what has been previously done for sirtuins [52]. Such
an analysis is essential in order to interpret differential responses
to CR, as some genotypes may simply show a shifted nutrient
response proﬁle while others may show true differential re-
sponse to nutrient restriction across all levels of restriction
(Fig. 2).
3.4. Epistasis with additional longevity factors
Another powerful feature of yeast as a model system for aging-
related research is that there is a large body of literature on path-
ways that inﬂuence replicative and/or chronological life span and
their interaction with CR [35,37,53,54]. For example, deletion of
SIR2 blocks replicative life span extension at all levels and methods
of restriction tested; however, CR extends replicative life span to a
greater extent when both SIR2 and FOB1 (which encodes a protein
involved in rDNA stability) are deleted, compared to wild type cells
[47]. CR can also extend replicative life span in wild type cells in
the absence of a functional mitochondrial respiratory chain, at
least under certain conditions [55]. Thus, combining select dele-
tions that show a differential response to CR with mutations in
SIR2, FOB1, or mitochondrial respiration is likely to be informative.
Likewise, mutations that decrease signaling through the TOR/Sch9/
PKA pathways, which are thought to mimic CR in the wild type
context [42,56,57], may also show differential longevity effects
depending on the genetic context.
3.5. Model system
The relevance of yeast as a model for human aging has been de-
bated elsewhere [58–60], but cannot truly be assessed until it is
possible to experimentally quantify rates of human aging through
reliable biomarkers. Clearly, some aspects of the CR response in
mammals, such as the marked reduction in inﬂammation [61–
63], will not be captured in the yeast model. There is reason to be-
lieve, however, that analysis of the genetic and molecular mecha-
nisms underlying the response to CR in yeast may yield insight
into similar mechanisms in mammals. It has now been quantita-
tively demonstrated that there is conservation of genetic control
of longevity between the yeast replicative aging paradigm and
aging in C. elegans [39]. Furthermore, the identiﬁcation of con-
served genetic pathways (e.g., TOR) and environmental manipula-
tions (e.g., CR) that regulate lifespan across an evolutionary diverse
set of organisms, coupled with the numerous advantages of yeast
as a model organism (ease of genetic manipulation, fast growth,
etc.) provides an impetus for continued utilization of yeast as a
model in aging research.ackgrounds at two different levels of calorie restriction. Data were obtained from the
span at each level of restriction relative to cells grown at 2% glucose in the same
f each strain is: BY4742 (MATa his3D1 leu2D0 lys2D0 ura3D0), PSY316 (MATa trp1–99
ura3–52 his3–11,15 RDN1::ADE2 RAD5).
0.05% Glucose
N Median percent change Range N
7 21 16 to 29 9
6 43 29 to 52 3
4 28 23 to 32 2
2872 J. Schleit et al. / FEBS Letters 586 (2012) 2868–28734. Conclusion
The impact of genetic variation on the response to CR has been
clearly demonstrated in laboratory animals, but the mechanisms
underlying these effects remain unknown. It also remains unclear
to what degree individual genetic variation will inﬂuence the ef-
fects of CR in outbred natural populations of common model
organisms. In addition, there is only limited data on the health con-
sequences of long term CR in humans. Thus, it is difﬁcult to predict
the degree to which genetic variation will lead to differential re-
sponses to CR in people. As the likelihood of widely available CR
mimetics becomes a reality, it will become increasingly more
important to answer these questions. Yeast provide a powerful
model system to begin doing so. By better deﬁning the molecular
processes that modulate the relationship between genotype and
CR in yeast, we can begin to develop hypotheses that can be tested
in more complex organisms and may ultimately provide important
information for individuals considering practicing CR or using a
putative CR mimetic drug.
Acknowledgements
Studies in the Kaeberlein Lab described here were supported by
NIH Grant R01AG039390. JS and BMW were supported by NIH
Training Grant T32ES007032. MK is an Ellison Medical Foundation
New Scholar in Aging.
References
[1] McCay, C.M., Crowell, M.F. and Maynard, L.A. (1935) The effect of retarded
growth upon the length of life and upon ultimate size. J. Nutr. 10, 63–79.
[2] Anderson, R.M. and Weindruch, R. (2010) Metabolic reprogramming, caloric
restriction and aging. Trends Endocrinol. Metab. 21, 134–141.
[3] Masoro, E.J. (2005) Overview of caloric restriction and ageing. Mech. Ageing
Dev. 126, 913–922.
[4] Kennedy, B.K., Steffen, K.K. and Kaeberlein, M. (2007) Ruminations on dietary
restriction and aging. Cell. Mol. Life Sci. 64, 1323–1328.
[5] Weindruch, R., Walford, R.L., Fligiel, S. and Guthrie, D. (1986) The retardation
of aging in mice by dietary restriction: longevity, cancer, immunity and
lifetime energy intake. J. Nutr. 116, 641–654.
[6] Omodei, D. and Fontana, L. (2011) Calorie restriction and prevention of age-
associated chronic disease. FEBS Lett. 585, 1537–1542.
[7] Colman, R.J., Anderson, R.M., Johnson, S.C., Kastman, E.K., Kosmatka, K.J.,
Beasley, T.M., Allison, D.B., Cruzen, C., Simmons, H.A., Kemnitz, J.W. and
Weindruch, R. (2009) Caloric restriction delays disease onset and mortality in
rhesus monkeys. Science 325, 201–204.
[8] Holloszy, J.O. and Fontana, L. (2007) Caloric restriction in humans. Exp.
Gerontol. 42, 709–712.
[9] Rickman, A.D., Williamson, D.A., Martin, C.K., Gilhooly, C.H., Stein, R.I., Bales,
C.W., Roberts, S. and Das, S.K. (2011) The CALERIE Study: design and methods
of an innovative 25% caloric restriction intervention. Contemp Clin Trials. 32,
874–881.
[10] Fontana, L., Klein, S. and Holloszy, J.O. (2010) Effects of long-term calorie
restriction and endurance exercise on glucose tolerance, insulin action, and
adipokine production. Age (Dordr). 32, 97–108.
[11] Fontana, L., Meyer, T.E., Klein, S. and Holloszy, J.O. (2004) Long-term calorie
restriction is highly effective in reducing the risk for atherosclerosis in
humans. Proc. Natl. Acad. Sci. U S A 101, 6659–6663.
[12] Greer, E.L., Banko, M.R. and Brunet, A. (2009) AMP-activated protein kinase
and FoxO transcription factors in dietary restriction-induced longevity. Ann.
N. Y. Acad. Sci. 1170, 688–692.
[13] Mair, W. and Dillin, A. (2008) Aging and survival: the genetics of life span
extension by dietary restriction. Annu. Rev. Biochem. 77, 727–754.
[14] Katewa, S.D. and Kapahi, P. (2010) Dietary restriction and aging, 2009. Aging
Cell 9, 105–112.
[15] Kapahi, P., Chen, D., Rogers, A.N., Katewa, S.D., Li, P.W., Thomas, E.L. and
Kockel, L. (2010) With TOR, less is more: a key role for the conserved nutrient-
sensing TOR pathway in aging. Cell Metab. 11, 453–465.
[16] Salih, D.A. and Brunet, A. (2008) FoxO transcription factors in the maintenance
of cellular homeostasis during aging. Curr. Opin. Cell Biol. 20, 126–136.
[17] Ingram, D.K., Zhu, M., Mamczarz, J., Zou, S., Lane, M.A., Roth, G.S. and deCabo,
R. (2006) Calorie restriction mimetics: an emerging research ﬁeld. Aging Cell
5, 97–108.
[18] Kaeberlein, M. (2010) Resveratrol and rapamycin: are they anti-aging drugs?
BioEssays 32, 96–99.
[19] Milne, J.C., Lambert, P.D., Schenk, S., Carney, D.P., Smith, J.J., Gagne, D.J., Jin, L.,
Boss, O., Perni, R.B., Vu, C.B., Bemis, J.E., Xie, R., Disch, J.S., Ng, P.Y., Nunes, J.J.,Lynch, O., Yang, H., Galonek, H., Israelian, K., Choy, W., Ifﬂand, A., Lavu, S.,
Medvedik, O., Sinclair, D.A., Olefsky, J.M., Jirousek, M.R., Elliott, P.J. and
Westphal, C.H. (2007) Small molecule activators of SIRT1 as therapeutics for
the treatment of type 2 diabetes. Nature 450, 712–716.
[20] Houtkooper, R.H., Pirinen, E. and Auwerx, J. (2012) Sirtuins as regulators of
metabolism and healthspan. Nat. Rev. Mol. Cell Biol. 13, 225–238.
[21] Canto, C. and Auwerx, J. (2011) Calorie restriction: is AMPK a key sensor and
effector? Physiology (Bethesda) 26, 214–224.
[22] Blagosklonny, M.V. (2010) Increasing healthy lifespan by suppressing aging in
our lifetime: preliminary proposal. Cell Cycle 9, 4788–4794.
[23] Blagosklonny, M.V. (2007) An anti-aging drug today: from senescence-
promoting genes to anti-aging pill. Drug Discovery Today 12, 218–224.
[24] Swindell, W.R. (2011) Dietary restriction in rats and mice. A meta-analysis and
review of the evidence for genotype-dependent effects on lifespan. Ageing Res.
Rev. 11, 254–270.
[25] Panowski, S.H., Wolff, S., Aguilaniu, H., Durieux, J. and Dillin, A. (2007) PHA-4/
Foxa mediates diet-restriction-induced longevity of C. elegans. Nature 447,
550–555.
[26] Steinkraus, K.A., Smith, E.D., Davis, C., Carr, D., Pendergrass, W.R., Sutphin, G.L.,
Kennedy, B.K. and Kaeberlein, M. (2008) Dietary restriction suppresses
proteotoxicity and enhances longevity by an hsf-1-dependent mechanism in
Caenorhabditis elegans. Aging Cell 7, 394–404.
[27] Artal-Sanz, M. and Tavernarakis, N. (2009) Prohibitin couples diapause
signalling to mitochondrial metabolism during ageing in C. elegans. Nature
461, 793–797.
[28] Bennett, B. and Johnson, T.E. (1998) Development of congenics for hypnotic
sensitivity to ethanol by QTL-marker-assisted counter selection. Mammalian
genome: ofﬁcial journal of the International Mammalian Genome Society. 9,
969–974.
[29] Bennett, B., Beeson, M., Gordon, L. and Johnson, T.E. (2002) Reciprocal
congenics deﬁning individual quantitative trait Loci for sedative/hypnotic
sensitivity to ethanol. Alcohol. Clin. Exp. Res. 26, 149–157.
[30] Liao, C.Y., Rikke, B.A., Johnson, T.E., Diaz, V. and Nelson, J.F. (2010) Genetic
variation in the murine lifespan response to dietary restriction: from life
extension to life shortening. Aging Cell 9, 92–95.
[31] Fernandes, G., Yunis, E.J. and Good, R.A. (1976) Inﬂuence of diet on survival of
mice. Proc. Natl. Acad. Sci. U S A 73, 1279–1283.
[32] Harper, J.M., Leathers, C.W. and Austad, S.N. (2006) Does caloric restriction
extend life in wild mice? Aging Cell 5, 441–449.
[33] Liao, C.Y., Rikke, B.A., Johnson, T.E., Gelfond, J.A., Diaz, V. and Nelson, J.F. (2011)
Fat maintenance is a predictor of the murine lifespan response to dietary
restriction. Aging Cell 10, 629–639.
[34] Harrison, D.E., Archer, J.R. and Astle, C.M. (1984) Effects of food restriction on
aging: separation of food intake and adiposity. Proc. Natl. Acad. Sci. U S A 81,
1835–1838.
[35] Kaeberlein, M. (2010) Lessons on longevity from budding yeast. Nature 464,
513–519.
[36] Mortimer, R.K. and Johnston, J.R. (1959) Life span of individual yeast cells.
Nature 183, 1751–1752.
[37] Fabrizio, P. and Longo, V.D. (2007) The chronological life span of
Saccharomyces cerevisiae. Methods Mol. Biol. 371, 89–95.
[38] Gershon, H. and Gershon, D. (2000) The budding yeast. Saccharomyces
cerevisiae, as a model for aging research: a critical review, Mech Ageing Dev.
120, 1–22.
[39] Smith, E.D., Tsuchiya, M., Fox, L.A., Dang, N., Hu, D., Kerr, E.O., Johnston, E.D.,
Tchao, B.N., Pak, D.N., Welton, K.L., Promislow, D.E., Thomas, J.H., Kaeberlein,
M. and Kennedy, B.K. (2008) Quantitative evidence for conserved longevity
pathways between divergent eukaryotic species. Genome Res. 18, 564–570.
[40] Kaeberlein, M., McVey, M. and Guarente, L. (1999) The SIR2/3/4 complex and
SIR2 alone promote longevity in Saccharomyces cerevisiae by two different
mechanisms. Gene Dev. 13, 2570–2580.
[41] Fabrizio, P., Pozza, F., Pletcher, S.D., Gendron, C.M. and Longo, V.D. (2001)
Regulation of longevity and stress resistance by Sch9 in yeast. Science 292,
288–290.
[42] Kaeberlein, M., Powers 3rd, R.W., Steffen, K.K., Westman, E.A., Hu, D., Dang, N.,
Kerr, E.O., Kirkland, K.T., Fields, S. and Kennedy, B.K. (2005) Regulation of yeast
replicative life span by TOR and Sch9 in response to nutrients. Science 310,
1193–1196.
[43] Stanfel, M.N., Shamieh, L.S., Kaeberlein, M. and Kennedy, B.K. (2009) The TOR
pathway comes of age. Biochim. Biophys. Acta 1790, 1067–1074.
[44] Yilmaz, O.H., Katajisto, P., Lamming, D.W., Gultekin, Y., Bauer-Rowe, K.E.,
Sengupta, S., Birsoy, K., Dursun, A., Yilmaz, V.O., Selig, M., Nielsen, G.P., Mino-
Kenudson, M., Zukerberg, L.R., Bhan, A.K., Deshpande, V. and Sabatini, D.M.
(2012) MTORC1 in the Paneth cell niche couples intestinal stem-cell function
to calorie intake. Nature 486, 490–495.
[45] Harrison, D.E., Strong, R., Sharp, Z.D., Nelson, J.F., Astle, C.M., Flurkey, K.,
Nadon, N.L., Wilkinson, J.E., Frenkel, K., Carter, C.S., Pahor, M., Javors, M.A.,
Fernandez, E. and Miller, R.A. (2009) Rapamycin fed late in life extends
lifespan in genetically heterogeneous mice. Nature 460, 392–395.
[46] Delaney, J.R., Sutphin, G.L., Dulken, B., Sim, S., Kim, J.R., Robison, B., Schleit, J.,
Murakami, C.J., Carr, D., An, E.H., Choi, E., Chou, A., Fletcher, M., Jelic, M., Liu, B.,
Lockshon, D., Moller, R.M., Pak, D.N., Peng, Q., Peng, Z.J., Pham, K.M., Sage, M.,
Solanky, A., Steffen, K.K., Tsuchiya, M., Tsuchiyama, S., Johnson, S., Raabe, C.,
Suh, Y., Zhou, Z., Liu, X., Kennedy, B.K. and Kaeberlein, M. (2011) Sir2 deletion
prevents lifespan extension in 32 long-lived mutants. Aging Cell 10, 1089–
1091.
J. Schleit et al. / FEBS Letters 586 (2012) 2868–2873 2873[47] Kaeberlein, M., Kirkland, K.T., Fields, S. and Kennedy, B.K. (2004) Sir2-
independent life span extension by calorie restriction in yeast. PLoS Biol. 2,
E296.
[48] Lin, S.J., Kaeberlein, M., Andalis, A.A., Sturtz, L.A., Defossez, P., Culotta, V.C.,
Fink, G. and Guarente, L. (2002) Calorie restriction extends Saccharomyces
cerevisiae life span by increasing respiration. Nature 418, 344–348.
[49] Kaeberlein, M. and Kennedy, B.K. (2005) Large-scale identiﬁcation in yeast of
conserved aging genes. Mech. Ageing Dev. 126, 17–21.
[50] Winzeler, E.A., Shoemaker, D.D., Astromoff, A., Liang, H., Anderson, K., Andre,
B., Bangham, R., Benito, R., Boeke, J.D., Bussey, H., Chu, A.M., Connelly, C., Davis,
K., Dietrich, F., Dow, S.W., El Bakkoury, M., Foury, F., Friend, S.H., Gentalen, E.,
Giaever, G., Hegemann, J.H., Jones, T., Laub, M., Liao, H. and Davis, R.W. (1999)
Functional characterization of the S. cerevisiae genome by gene deletion and
parallel analysis. Science 285, 901–906.
[51] Kaeberlein, M., Steffen, K.K., Hu, D., Dang, N., Kerr, E.O., Tsuchiya, M., Fields, S.
and Kennedy, B.K. (2006) Comment on ‘‘HST2 mediates SIR2-independent life-
span extension by calorie restriction’’. Science 312, 1312. author reply 1312.
[52] Tsuchiya, M., Dang, N., Kerr, E.O., Hu, D., Steffen, K.K., Oakes, J.A., Kennedy, B.K.
and Kaeberlein, M. (2006) Sirtuin-independent effects of nicotinamide on
lifespan extension from calorie restriction in yeast. Aging Cell 5, 505–514.
[53] Longo, V.D., Shadel, G.S., Kaeberlein, M. and Kennedy, B.K. (2012) Replicative
and chronological aging in Saccharomyces cerevisiae. Cell Metab. 16, 18–31.
[54] Steinkraus, K.A., Kaeberlein, M. and Kennedy, B.K. (2008) Replicative aging in
yeast: the means to the end. Annu. Rev. Cell Dev. Biol. 24, 29–54.
[55] Kaeberlein, M., Hu, D., Kerr, E.O., Tsuchiya, M., Westman, E.A., Dang, N., Fields,
S. and Kennedy, B.K. (2005) Increased life span due to calorie restriction in
respiratory-deﬁcient yeast. PLoS Genet. 1, e69.
[56] Lin, S.J., Defossez, P.A. and Guarente, L. (2000) Requirement of NAD and SIR2
for life-span extension by calorie restriction in Saccharomyces cerevisiae.
Science 289, 2126–2128.
[57] Fabrizio, P., Pletcher, S.D., Minois, N., Vaupel, J.W. and Longo, V.D. (2004)
Chronological aging-independent replicative life span regulation by Msn2/
Msn4 and Sod2 in Saccharomyces cerevisiae. FEBS Lett. 557, 136–142.
[58] Gershon, H. and Gershon, D. (2000) Paradigms in aging research: a critical
review and assessment. Mech. Ageing Dev. 117, 21–28.
[59] Gershon, H. and Gershon, D. (2001) Critical assessment of paradigms in aging
research. Exp. Gerontol. 36, 1035–1047.
[60] Kaeberlein, M., McVey, M. and Guarente, L. (2001) Using yeast to discover the
fountain of youth. Sci Aging Knowledge Environ., pe1.[61] Gonzalez, O., Tobia, C., Ebersole, J. and Novak, M.J. (2012) Caloric restriction
and chronic inﬂammatory diseases. Oral Dis. 18, 16–31.
[62] Chung, H.Y., Cesari, M., Anton, S., Marzetti, E., Giovannini, S., Seo, A.Y., Carter,
C., Yu, B.P. and Leeuwenburgh, C. (2009) Molecular inﬂammation:
underpinnings of aging and age-related diseases. Ageing Res Rev. 8, 18–30.
[63] Morgan, T.E., Wong, A.M. and Finch, C.E. (2007) Anti-inﬂammatory
mechanisms of dietary restriction in slowing aging processes. Interdiscip.
Top. Gerontol. 35, 83–97.
[64] Easlon, E., Tsang, F., Dilova, I., Wang, C., Lu, S.P., Skinner, C. and Lin, S.J. (2007)
The dihydrolipoamide acetyltransferase is a novel metabolic longevity factor
and is required for calorie restriction-mediated life span extension. J. Biol.
Chem. 282, 6161–6171.
[65] Kaeberlein, M., Andalis, A.A., Fink, G.R. and Guarente, L. (2002) High
osmolarity extends life span in Saccharomyces cerevisiae by a mechanism
related to calorie restriction. Mol. Cell. Biol. 22, 8056–8066.
[66] Kaeberlein, M., Kirkland, K.T., Fields, S. and Kennedy, B.K. (2005) Genes
determining replicative life span in a long-lived genetic background. Mech.
Ageing Dev. 126, 491–504.
[67] Kruegel, U., Robison, B., Dange, T., Kahlert, G., Delaney, J.R., Kotireddy, S.,
Tsuchiya, M., Tsuchiyama, S., Murakami, C.J., Schleit, J., Sutphin, G., Carr, D.,
Tar, K., Dittmar, G., Kaeberlein, M., Kennedy, B.K. and Schmidt, M. (2011)
Elevated Proteasome Capacity Extends Replicative Lifespan in Saccharomyces
cerevisiae. PLoS Genet. 7, e1002253.
[68] Lamming, D.W., Latorre-Esteves, M., Medvedik, O., Wong, S.N., Tsang, F.A.,
Wang, C., Lin, S.J. and Sinclair, D.A. (2005) HST2 mediates SIR2-independent
life-span extension by calorie restriction. Science 309, 1861–1864.
[69] Medvedik, O., Lamming, D.W., Kim, K.D. and Sinclair, D.A. (2007) MSN2 and
MSN4 link calorie restriction and TOR to sirtuin-mediated lifespan extension
in Saccharomyces cerevisiae. PLoS Biol. 5, e261.
[70] Anderson, R.M., Bitterman, K.J., Wood, J.G., Medvedik, O., Cohen, H., Lin, S.S.,
Manchester, J.K., Gordon, J.I. and Sinclair, D.A. (2002) Manipulation of a
nuclear NAD+ salvage pathway delays aging without altering steady-state
NAD+ levels. J. Biol. Chem. 7, 7.
[71] Anderson, R.M., Bitterman, K.J., Wood, J.G., Medvedik, O. and Sinclair, D.A.
(2003) Nicotinamide and PNC1 govern lifespan extension by caloric restriction
in Saccharomyces cerevisiae. Nature 423, 181–185.
[72] Kaeberlein, M., Andalis, A.A., Liszt, G.B., Fink, G.R. and Guarente, L. (2004)
Saccharomyces cerevisiae SSD1-V confers longevity by a Sir2p-independent
mechanism. Genetics 166, 1661–1672.
